Indutrade AB (publ) INDT
Email when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
The news check keeps the assessment current.
General analysis — not personal advice.
Consider adding in steps (e.g., 2–3 tranches) rather than all at once, as the stock can trade mixed even after strong results. If already overweight: add only on weakness or keep weight and seek confirmation in coming quarters.
Strong order intake, record margins and continued acquisition activity support the growth outlook.
Sentiment remains positive with focus on margin expansion, organic growth and continued high M&A activity.
BUY is the call. Positive is the market mood. Medium risk means some things can go wrong.
Latest change
- 24 Oct 2026 — Order intake rose 16 % and EBITA margin reached 15.3 %; three acquisitions added approximately 450 MSEK in annual revenue.
The full analysis is open. Follow the company free for the full change history — and email next time the picture changes.
Show all changes (7) — follow the company freeAbout the company
Indutrade is an acquisition-driven industrial group focused on technical trading, selling niche industrial components, systems and services. It operates a highly decentralized model through 200+ subsidiaries across many countries, combining stable profitability with M&A-led growth. Recently weak organic growth has increased focus on efficiency measures and deal pace.
Bull case
High organic growth, improved profitability and a strong acquisition pipeline provide good visibility for earnings growth.
Bear case
Macroeconomic and geopolitical uncertainty together with longer lead times in the order book may dampen short-term organic growth.
Why this signal
Strong order intake, record margins and continued acquisition activity support the growth outlook.
Recent news
The Q3 report was released on 23 October showing order intake up 16 % and EBITA margin rising to 15.3 %. Three new acquisitions (Euromed, Sinmed, Schraner) added approximately SEK 450 million in annual revenue. The stock fell around 4–5 % on the report despite results in line with expectations, mainly due to longer lead times in the order book.